---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-25-000014"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T06:18:06.717901+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ICU Medical Q1 revenue up 7% to $605M; adjusted EPS $1.72 vs $0.96

## Summary
- Revenue $604.7M, up 6.7% YoY from $566.7M.
- GAAP net loss $(15.5)M ($0.63 loss per share) vs $(39.5)M ($1.63 loss) YoY.
- Adjusted diluted EPS $1.72, up from $0.96 in Q1 2024.
- Adjusted EBITDA $99.4M vs $78.8M YoY, a 26% increase.
- GAAP gross margin expanded to 35% from 33% in prior year.

## SEC filing metadata
- accession: 0000883984-25-000014
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398425000014/0000883984-25-000014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398425000014/icui-20250508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-25-000014
- JSON: https://secwatch.observer/filing/0000883984-25-000014.json
- Plain text: https://secwatch.observer/filing/0000883984-25-000014.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.